Their study revealed that mitochondrial biogenesis markers, including PGC-1α, NRF1, and TFAM, and mitochondrial fusion were decreased by TRPA1 blocker treatment in kidney tissues from either healthy or sepsis mouse. This evidence concerns the gene PPARGC1A and Sepsis.